Stay updated on Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Version 52 was added on 2026-05-11, updating Study Status and Contacts/Locations for this trial record. A revision entry, v3.5.4, was recorded on 2026-05-13 to reflect those updates.
    Difference
    0.3%
    Check dated 2026-05-15T09:13:07.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s footer/version identifier updates from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating an internal UI release rather than a change to the recorded clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-24T06:13:37.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:39:46.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    New revision entry v3.5.0 was added to the record history. Revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T04:55:34.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the history as the latest entry, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T00:35:40.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The study title now specifies Etentamig (ABBV-383) for intravenous use in adults with relapsed or refractory multiple myeloma, with related sections added or updated accordingly.
    Difference
    0.6%
    Check dated 2026-02-18T16:27:40.000Z thumbnail image

Stay in the know with updates to Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of IV ABBV-383 in Multiple Myeloma Clinical Trial page.